Identification of Hyaluronic Acid Binding Sites in the Extracellular Domain of CD44

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 1993 Jul 1

PMID 8314845

Citations 95

Authors

R J Peach

D Hollenbaugh

I Stamenkovic

A Aruffo

Affiliations

Soon will be listed here.

Abstract

CD44 is a polymorphic glycoprotein expressed on the surface of many tissues and cell lines which has been implicated in a number of cellular functions including lymphocyte homing to mucosal lymphoid tissue (Peyers patches), leukocyte activation, lymphopoiesis, and tumor metastasis. The predominant isoform found on human leukocytes, CD44H, is a receptor for hyaluronic acid. Because of the prominent role CD44 plays in diverse biological processes, we set out to identify the hyaluronic acid binding site(s) in the extracellular domain of CD44H. Using truncation and site-directed mutagenesis we identified two regions containing clusters of conserved basic residues which are important in hyaluronic acid binding. One of these regions is situated near the NH2 terminus and is homologous to other hyaluronic acid binding proteins including cartilage link protein. The other more membrane proximal region lies outside the link protein homologous domain. Mutagenesis of basic residues within these regions established their role as determinants in hyaluronic acid binding. Mutation of Arg 41, a position where a basic residue is conserved in all hyaluronic acid binding proteins, completely abolished binding suggesting that this residue plays a critical role in hyaluronic acid binding.

Citing Articles

Extending the Martini 3 Coarse-Grained Force Field to Hyaluronic Acid.

Lutsyk V, Plazinski W J Phys Chem B. 2025; 129(9):2408-2425.

PMID: 39988846 PMC: 11891902. DOI: 10.1021/acs.jpcb.4c08043.

RNA Sequencing Revealed a Weak Response of Gingival Fibroblasts Exposed to Hyaluronic Acid.

Panahipour L, Imani A, Dos Santos Sanches N, Kuhtreiber H, Mildner M, Gruber R Bioengineering (Basel). 2025; 11(12.

PMID: 39768125 PMC: 11726844. DOI: 10.3390/bioengineering11121307.

Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.

Lee S, Lee S, Shinn J, Lee Y Int J Nanomedicine. 2024; 19:4893-4906.

PMID: 38828202 PMC: 11141580. DOI: 10.2147/IJN.S460468.

Preparation and Characterization of Collagen-Hyaluronic Acid (Col-HA) Matrices: In Vitro Mimics of the Tumor Microenvironment.

Dutta S, Sen S Methods Mol Biol. 2023; 2747:131-139.

PMID: 38038937 DOI: 10.1007/978-1-0716-3589-6_11.

Prostaglandin E Boosts the Hyaluronan-Mediated Increase in Inflammatory Response to Lipopolysaccharide by Enhancing Lyve1 Expression.

Hog P, Kuntschar S, Rappl P, Huard A, Weigert A, Brune B Biology (Basel). 2023; 12(11).

PMID: 37998039 PMC: 10669677. DOI: 10.3390/biology12111441.

References

Hughes E, Mengod G, August J . Murine cell surface glycoproteins. Characterization of a major component of 80,000 daltons as a polymorphic differentiation antigen of mesenchymal cells. J Biol Chem. 1981; 256(13):7023-7. View

Culty M, Miyake K, Kincade P, Sikorski E, Butcher E, Underhill C . The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol. 1990; 111(6 Pt 1):2765-74. PMC: 2116369. DOI: 10.1083/jcb.111.6.2765. View

Stamenkovic I, Aruffo A, Amiot M, Seed B . The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 1991; 10(2):343-8. PMC: 452652. DOI: 10.1002/j.1460-2075.1991.tb07955.x. View

Jackson R, Busch S, Cardin A . Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev. 1991; 71(2):481-539. DOI: 10.1152/physrev.1991.71.2.481. View

Brown T, Bouchard T, John T, Wayner E, Carter W . Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol. 1991; 113(1):207-21. PMC: 2288920. DOI: 10.1083/jcb.113.1.207. View

Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I . A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991; 65(1):13-24. DOI: 10.1016/0092-8674(91)90403-l. View

HYMAN R, Lesley J, Schulte R . Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding. Immunogenetics. 1991; 33(5-6):392-5. DOI: 10.1007/BF00216699. View

Sy M, Guo Y, Stamenkovic I . Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med. 1991; 174(4):859-66. PMC: 2118964. DOI: 10.1084/jem.174.4.859. View

Shtivelman E, Bishop J . Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol. 1991; 11(11):5446-53. PMC: 361913. DOI: 10.1128/mcb.11.11.5446-5453.1991. View

10.

Bosworth B, John T, Gallatin W, Harp J . Sequence of the bovine CD44 cDNA: comparison with human and mouse sequences. Mol Immunol. 1991; 28(10):1131-5. DOI: 10.1016/0161-5890(91)90028-i. View

11.

Camp R, Kraus T, Pure E . Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages. J Cell Biol. 1991; 115(5):1283-92. PMC: 2289237. DOI: 10.1083/jcb.115.5.1283. View

12.

Lee T, Wisniewski H, Vilcek J . A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J Cell Biol. 1992; 116(2):545-57. PMC: 2289279. DOI: 10.1083/jcb.116.2.545. View

13.

Jalkanen S, Jalkanen M . Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol. 1992; 116(3):817-25. PMC: 2289325. DOI: 10.1083/jcb.116.3.817. View

14.

Lesley J, He Q, Miyake K, Hamann A, HYMAN R, Kincade P . Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med. 1992; 175(1):257-66. PMC: 2119065. DOI: 10.1084/jem.175.1.257. View

15.

Jackson D, Buckley J, Bell J . Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem. 1992; 267(7):4732-9. View

16.

Aruffo A, Dietsch M, Wan H, Hellstrom K, Hellstrom I . Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines. Proc Natl Acad Sci U S A. 1992; 89(6):2292-6. PMC: 48643. DOI: 10.1073/pnas.89.6.2292. View

17.

LeBaron R, Zimmermann D, Ruoslahti E . Hyaluronate binding properties of versican. J Biol Chem. 1992; 267(14):10003-10. View

18.

Thomas L, Byers H, Vink J, Stamenkovic I . CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol. 1992; 118(4):971-7. PMC: 2289565. DOI: 10.1083/jcb.118.4.971. View

19.

Screaton G, Bell M, Jackson D, Cornelis F, Gerth U, Bell J . Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A. 1992; 89(24):12160-4. PMC: 50718. DOI: 10.1073/pnas.89.24.12160. View

20.

He Q, Lesley J, HYMAN R, Ishihara K, Kincade P . Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol. 1992; 119(6):1711-9. PMC: 2289747. DOI: 10.1083/jcb.119.6.1711. View